1. Home
  2. MDXG vs BXC Comparison

MDXG vs BXC Comparison

Compare MDXG & BXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • BXC
  • Stock Information
  • Founded
  • MDXG 2006
  • BXC 2004
  • Country
  • MDXG United States
  • BXC United States
  • Employees
  • MDXG N/A
  • BXC N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • BXC Wholesale Distributors
  • Sector
  • MDXG Health Care
  • BXC Consumer Discretionary
  • Exchange
  • MDXG Nasdaq
  • BXC Nasdaq
  • Market Cap
  • MDXG 1.1B
  • BXC 1.0B
  • IPO Year
  • MDXG N/A
  • BXC 2004
  • Fundamental
  • Price
  • MDXG $9.10
  • BXC $107.11
  • Analyst Decision
  • MDXG Strong Buy
  • BXC Strong Buy
  • Analyst Count
  • MDXG 5
  • BXC 3
  • Target Price
  • MDXG $12.00
  • BXC $135.67
  • AVG Volume (30 Days)
  • MDXG 814.8K
  • BXC 53.0K
  • Earning Date
  • MDXG 10-30-2024
  • BXC 02-18-2025
  • Dividend Yield
  • MDXG N/A
  • BXC N/A
  • EPS Growth
  • MDXG N/A
  • BXC N/A
  • EPS
  • MDXG 0.52
  • BXC 3.41
  • Revenue
  • MDXG $342,804,000.00
  • BXC $2,954,424,000.00
  • Revenue This Year
  • MDXG $9.56
  • BXC N/A
  • Revenue Next Year
  • MDXG $9.19
  • BXC $4.71
  • P/E Ratio
  • MDXG $18.08
  • BXC $31.34
  • Revenue Growth
  • MDXG 10.93
  • BXC N/A
  • 52 Week Low
  • MDXG $5.47
  • BXC $87.67
  • 52 Week High
  • MDXG $10.14
  • BXC $134.79
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 53.38
  • BXC 30.45
  • Support Level
  • MDXG $9.07
  • BXC $105.75
  • Resistance Level
  • MDXG $9.60
  • BXC $126.45
  • Average True Range (ATR)
  • MDXG 0.32
  • BXC 4.23
  • MACD
  • MDXG -0.16
  • BXC -2.70
  • Stochastic Oscillator
  • MDXG 14.05
  • BXC 5.59

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

About BXC Bluelinx Holdings Inc.

BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.

Share on Social Networks: